Hong Kong-based devicemaker OrbusNeich and German cardiac device firm P+F (Products and Features) have reached a manufacturing and distribution agreement for P+F’s minimally invasive heart valve devices.

P+F brings a range of cardiac products to the deal, including its TricValve transcatheter bicaval valves, its Vienna Aortic self-expandable transcatheter valve, endovascular grafts and other transcatheter products for pulmonary and mitral valve disease.

Under the agreement, OrbusNeich will market the P+F devices in China, Japan, Taiwan, South Korea, Singapore, Malaysia, Australia, New Zealand and Hong Kong.